MCK vs COR — Key Metrics
| Metric | MCK (MCKESSON CORP) | COR (CENCORA INC) |
|---|---|---|
| Price | 1084.43 | 348.31 |
| Market Cap | 125.2 Billion | 66.47 Billion |
| P/E (TTM) | 27.81 | 25.76 |
| P/B (Quarterly) | -31.228 | 19.841 |
| P/S (TTM) | 0.3 | 0.2 |
| Net Profit Margin (TTM) | 1.1 | 0.8 |
| Gross Margin (TTM) | 3.7 | 4.0 |
| ROE (TTM) | -161.2 | 106.4 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Outperform
Outperform
Recommendation Summary
Stock MCK is projected to greatly outperform the market, stock COR is projected to outperform the market. Upfront Recommendation: MCK.
Financial Metrics
| MCK | Metrics | COR |
|---|---|---|
| $1,084.43 | Price | $348.31 |
| — | Market Capitalization | — |
| 27.81 | Price to Earnings Ratio | 25.76 |
| 0.3 | Price to Sales | 0.2 |
| 18.23 | Price to FCF Ratio | 16.19 |
| 8.15 | Price to Gross Profit | 5.03 |
| 1.88 | Price to Current Assets | 1.2 |
MCK vs COR at a glance
Mckesson Corp (MCK) and Cencora INC (COR) are both Medical Distribution companies in the Healthcare sector. MCK is the larger, at $125.2 billion in market value against $66.5 billion for COR, about 1.9 times the size.
On trailing-twelve-month figures, MCK trades at 27.8 times trailing earnings and COR at 25.8; net profit margins are 1.1% and 0.8%.
The Upfront Investment model currently rates MCK Greatly Outperform and COR Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.